Refile: BRIEF-Pixium Vision Announces Its PRIMA Chip Meets Interim Study Endpoints For Dry AMD
08/01/2019 06:08
(Adds dropped word 'meets' in headline)
Jan 8 (Reuters) - PIXIUM VISION SA PIX.PA :
* REG-PIXIUM VISION ANNOUNCES ITS PRIMA CHIP SUCCESSFULLY
MET
INTERIM STUDY ENDPOINTS FOR DRY AMD
* IMPLANT IS WELL TOLERATED WHILE PRESERVING RESIDUAL
PERIPHERAL
VISUAL ACUITY
* MAJORITY OF PATIENTS IDENTIFYING COMPLEX PATTERNS, LETTERS
OR
LETTER SEQUENCES
* ALL SUBJECTS REPORT LIGHT PERCEPTION IN THEIR CENTRAL
VISUAL
FIELD
Source text for Eikon: ID:nGNE6kvm8f
Further company coverage: PIX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow